BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 22020805)

  • 1. Characterisation of in vivo ovarian cancer models by quantitative 1H magnetic resonance spectroscopy and diffusion-weighted imaging.
    Canese R; Pisanu ME; Mezzanzanica D; Ricci A; Paris L; Bagnoli M; Valeri B; Spada M; Venditti M; Cesolini A; Rodomonte A; Giannini M; Canevari S; Podo F; Iorio E
    NMR Biomed; 2012 Apr; 25(4):632-42. PubMed ID: 22020805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.
    Reinsberg SA; Payne GS; Riches SF; Ashley S; Brewster JM; Morgan VA; deSouza NM
    AJR Am J Roentgenol; 2007 Jan; 188(1):91-8. PubMed ID: 17179350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive monitoring of radiation-induced treatment response using proton magnetic resonance spectroscopy and diffusion-weighted magnetic resonance imaging in a colorectal tumor model.
    Seierstad T; Røe K; Olsen DR
    Radiother Oncol; 2007 Nov; 85(2):187-94. PubMed ID: 17937968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration.
    Mahon MM; Williams AD; Soutter WP; Cox IJ; McIndoe GA; Coutts GA; Dina R; deSouza NM
    NMR Biomed; 2004 Feb; 17(1):1-9. PubMed ID: 15011245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of MRI and MRS approaches to monitor molecular imaging and metabolomic effects of trabectedin on a preclinical ovarian cancer model.
    Canese R; Palombelli G; Chirico M; Sestili P; Bagnoli M; Canevari S; Mezzanzanica D; Podo F; Iorio E
    NMR Biomed; 2019 Oct; 32(10):e4016. PubMed ID: 30375088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla.
    Booth SJ; Pickles MD; Turnbull LW
    BJOG; 2009 Jan; 116(2):300-3. PubMed ID: 19076962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
    Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
    Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and MRS.
    Shin HJ; Baek HM; Ahn JH; Baek S; Kim H; Cha JH; Kim HH
    NMR Biomed; 2012 Dec; 25(12):1349-59. PubMed ID: 22566277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of water diffusion and relaxation times of human U87 tumors in a mouse model.
    Sun Y; Mulkern RV; Schmidt K; Doshi S; Albert MS; Schmidt NO; Ziu M; Black P; Carrol R; Kieran MW
    NMR Biomed; 2004 Oct; 17(6):399-404. PubMed ID: 15386627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance spectroscopy and diffusion tensor imaging in coma survivors: promises and pitfalls.
    Tshibanda L; Vanhaudenhuyse A; Galanaud D; Boly M; Laureys S; Puybasset L
    Prog Brain Res; 2009; 177():215-29. PubMed ID: 19818904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
    Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
    Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of quantitative cerebral T2 relaxometry, diffusion tensor imaging, and 1H magnetic resonance spectroscopy at 3.0 Tesla.
    Jansen JF; Kooi ME; Kessels AG; Nicolay K; Backes WH
    Invest Radiol; 2007 Jun; 42(6):327-37. PubMed ID: 17507802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted MR of the brain: methodology and clinical application.
    Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
    Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of apparent diffusion coefficient values for the differentiation of viable and necrotic areas of breast cancer and its potential utility to guide voxel positioning for MRS in the absence of dynamic contrast-enhanced MRI data.
    Sharma U; Sah RG; Parshad R; Sharma R; Seenu V; Jagannathan NR
    Magn Reson Imaging; 2012 Jun; 30(5):649-55. PubMed ID: 22459442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS.
    Jensen LR; Huuse EM; Bathen TF; Goa PE; Bofin AM; Pedersen TB; Lundgren S; Gribbestad IS
    NMR Biomed; 2010 Jan; 23(1):56-65. PubMed ID: 19650073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted imaging as predictor of therapy response in an animal model of Ewing sarcoma.
    Reichardt W; Juettner E; Uhl M; Elverfeldt DV; Kontny U
    Invest Radiol; 2009 May; 44(5):298-303. PubMed ID: 19346963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.